Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,672 | 442 | 95.7% |
| Gift | $262.89 | 1 | 3.8% |
| Education | $35.84 | 7 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,025 | 60 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $880.00 | 60 | $0 (2021) |
| PFIZER INC. | $678.98 | 52 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $633.57 | 37 | $0 (2021) |
| Novo Nordisk Inc | $533.33 | 37 | $0 (2021) |
| GlaxoSmithKline, LLC. | $479.98 | 32 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $348.29 | 30 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $303.14 | 19 | $0 (2020) |
| Allergan, Inc. | $298.45 | 23 | $0 (2020) |
| Tosoh Bioscience, Inc. | $262.89 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $520.96 | 31 | AstraZeneca Pharmaceuticals LP ($91.88) |
| 2020 | $1,013 | 63 | Lilly USA, LLC ($212.59) |
| 2019 | $1,342 | 84 | Lilly USA, LLC ($242.12) |
| 2018 | $1,653 | 111 | AstraZeneca Pharmaceuticals LP ($207.07) |
| 2017 | $2,442 | 161 | Lilly USA, LLC ($375.88) |
All Payment Transactions
450 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/02/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2021 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Neurology | ||||||
| 06/17/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.60 | General |
| 06/16/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $14.71 | General |
| Category: Cardiovascular | ||||||
| 05/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.07 | General |
| 05/05/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/04/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device), REYVOW | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: GASTROINTESTINAL | ||||||
| 04/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Diabetes | ||||||
| 04/14/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 04/07/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/01/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLUJAN, STEGLATRO | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/31/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Diabetes | ||||||
| 03/30/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/25/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: NEUROSCIENCE | ||||||
| 03/24/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| Category: Neurology | ||||||
| 03/18/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.82 | General |
| 03/12/2021 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Neurology | ||||||
| 03/04/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLUJAN, STEGLATRO | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/02/2021 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: OBESITY | ||||||
| 02/17/2021 | Bardy Diagnostics, Inc. | Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 02/11/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 9 | 328 | 376 | $48,856 | $16,782 |
| 2020 | 41 | 5,261 | 7,677 | $549,777 | $174,290 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 102 | 138 | $29,394 | $8,054 | 27.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 26 | 26 | $6,006 | $3,767 | 62.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 62 | $8,928 | $3,327 | 37.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 25 | 25 | $1,174 | $420.00 | 35.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 30 | 30 | $1,123 | $401.70 | 35.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 33 | 33 | $881.76 | $348.48 | 39.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 33 | 33 | $744.48 | $256.41 | 34.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 17 | 17 | $461.04 | $165.07 | 35.8% |
| 81002 | Urinalysis, manual test | Office | 2021 | 12 | 12 | $144.00 | $41.76 | 29.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 549 | 881 | $187,653 | $37,385 | 19.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 237 | 237 | $54,747 | $29,351 | 53.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 362 | 555 | $79,920 | $17,187 | 21.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 544 | 908 | $33,996 | $11,969 | 35.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 561 | 938 | $25,063 | $9,764 | 39.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2020 | 375 | 558 | $26,193 | $9,307 | 35.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 555 | 924 | $20,845 | $7,075 | 33.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 33 | 33 | $8,250 | $5,993 | 72.6% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 27 | 29 | $13,978 | $5,855 | 41.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2020 | 206 | 287 | $12,088 | $4,256 | 35.2% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 249 | 435 | $11,797 | $4,167 | 35.3% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 32 | 32 | $4,080 | $3,734 | 91.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 18 | 18 | $5,514 | $3,027 | 54.9% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 21 | 21 | $7,245 | $3,016 | 41.6% |
| 82746 | Folic acid level | Office | 2020 | 154 | 196 | $8,052 | $2,818 | 35.0% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 44 | 45 | $3,625 | $2,641 | 72.8% |
About Dr. Ciro Attardo, M.D
Dr. Ciro Attardo, M.D is a Family Medicine healthcare provider based in Chester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922052166.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ciro Attardo, M.D has received a total of $6,971 in payments from pharmaceutical and medical device companies, with $520.96 received in 2021. These payments were reported across 450 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,672).
As a Medicare-enrolled provider, Attardo has provided services to 5,589 Medicare beneficiaries, totaling 8,053 services with total Medicare billing of $191,072. Data is available for 2 years (2020–2021), covering 50 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Chester, NY
- Active Since 05/20/2006
- Last Updated 09/27/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1922052166
Products in Payments
- TRULICITY (Drug) $768.79
- FARXIGA (Drug) $698.32
- CHANTIX (Drug) $294.94
- JANUVIA (Drug) $273.25
- G8 Elution Buffer No. 1, 800mL (Medical Supply) $262.89
- JARDIANCE (Drug) $243.89
- ADVAIR (Drug) $224.05
- XARELTO (Drug) $221.71
- Trintellix (Drug) $209.91
- Vascepa (Drug) $201.21
- VRAYLAR (Drug) $198.94
- TRADJENTA (Drug) $179.63
- SPIRIVA RESPIMAT (Drug) $175.48
- STIOLTO (Drug) $164.75
- ENTRESTO (Drug) $140.01
- VIAGRA (Drug) $132.23
- XIFAXAN (Drug) $127.78
- Tresiba (Drug) $127.58
- BREO (Drug) $123.03
- Livalo (Drug) $115.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Chester
Andrew Rose, M.d, M.D
Family Medicine — Payments: $11,868
Mrs. Megan Caravas, Pa-C, PA-C
Family Medicine — Payments: $5,162
Samuel Stone, Md, MD
Family Medicine — Payments: $4,907
Douglas Beckwith, Md, MD
Family Medicine — Payments: $3,999
Thomas Yuen, Md, MD
Family Medicine — Payments: $3,566
James Krieg, Md, MD
Family Medicine — Payments: $3,323